期刊文献+

补阳还五汤合巴曲酶对急性脑梗死患者血浆溶血磷脂酸水平的影响 被引量:4

Influence of Buyang Huanwu Decotion(BYHWD)and Batroxobin on Plasma Level of Lysophosphatidic Acid in Patients with Acute Cerebral Infarction
下载PDF
导出
摘要 目的:研究补阳还五汤合巴曲酶对急性脑梗死患者血浆溶血磷脂酸(LPA)水平的影响。方法:56例急性脑梗死患者随机分为单用组(27例)和联合治疗组(29例),两组均给予巴曲酶治疗;联合组加用补阳还五汤治疗1个疗程。检测两组患者治疗前、治疗后5、7、14和21天的血浆LPA浓度,并与健康体检者(正常对照组)比较。结果 :两组治疗前血浆LPA水平显著高于正常对照组(均P<0.001);治疗后血浆LPA水平逐渐降低,联合组于治疗后14天、单用治疗组于治疗后21天与正常对照组相比差异无显著性(均P>0.05);联合组治疗后5、7、14天血浆LPA水平显著低于单用治疗组(均P<0.001),恢复正常亦早。结论:补阳还五汤合巴曲酶能显著降低急性脑梗死患者的血浆LPA水平,抑制血小板聚集。 Objective:To investigate the influence of Buyang Huanwu Decotion(BYHWD) and Batroxobin in on plasma level of lysophosphatidic ac id(LPA)in patients with acute cerebral infarction.Methods:A total of 56 patients with acute cerebral infarction were selected randomly to the alone group(n=27)o r the joint group(n=29).Batroxobin was used in both groups as basic treatment.BYHWD was used in the joint group for one course of treatment.The plasma levels of LPA were measured before treatment and 5th,7th,14th,and 21th day after treatment in both acute cerebral infraction groups,and compared with health volunteers(normal group).Results:The plasma levels of LPA in both groups were remarkably higher than that in normal group(all P0.001) and gradually decreased after treatment.There was no significant difference of plasma levels of LPA between normal group and the joint group at 14d or the alone group at 21 d after treatment(all P0.05).In the joint group the plasma levels of LPA were significantly lower than that in the alone group at 5th,7th,14th,21th day after treatment(all P0.001)and returned to normal earlier.Conclusions:BYHWD and Batroxobin can significantly decrease the plasma level of LPA and inhibit platelet aggregation in patients with acute cerebral infarction.
出处 《辽宁中医药大学学报》 CAS 2012年第11期172-173,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 巴曲酶 急性脑梗死 溶血磷脂酸 补阳还五汤 Batroxobin acute cerebra l infarction lysophosphatidic acid Buyang Huanwu Decotion
  • 相关文献

参考文献9

二级参考文献30

  • 1杨春娟.通心络对不稳定性心绞痛患者血脂影响的临床观察[J].中国中西医结合急救杂志,2004,11(4):238-238. 被引量:15
  • 2赵海霞,朵振顺,赵金霞,张继英,任志荣,马彪.短暂性脑缺血发作病人血浆溶血磷脂酸含量变化及其临床意义[J].中西医结合心脑血管病杂志,2007,5(6):534-535. 被引量:3
  • 3AntmanF3t, Girgliano RP, Gibaon CM, ET AL. Abciximab facili tates the rate and extent of thrombolysis: Results of the thrombolysis in Myocadical Infarction(TIM1) 14 trial [J]. Cerculation, 1999,99:2720~2732.
  • 4The Abcixlmab in ischemic stroke investigators. Abciximab in acute ischemic stroke. A randomized, double blind, placebo controlled,dose-escalation study[J]. Stroke, 2000,31: 601 ~ 609.
  • 5Belniak LE, Stemasiak Z. Blood platelet activation markers in pl tients with acute cerebral infarction during the earlist stage of the disease evaluation using flow cytometry methods[J] Neurol-Neuro chir-Pol, 2000,34(5) :853~64.
  • 6William GR, Jiang JG. Development of an Ischemia Stroke Survival Score[J]. Stroke, 2000 Oet, 31(10):2414~20.
  • 7Pasche BB, Ouimet H, Francis S, et al. Structural changes in plate let glycoprotein Ⅱ b/ Ⅲ a by plasmin: Determinants and Functional consequences[J]. Blood, 1994,83(2):404~414.
  • 8Longa EZ, Weinstein PN, Carlson S, et al. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 1989: 20(2) :84 -91.
  • 9Kumark, Harrey, SAK, et al. Production and effects of PAF in the rat brain. Biochem Biophts Acta 1998:963 - 375.
  • 10Sugano T, Nasu K, Narahara H, et al. Platelet-activating induces an imbalance between matrix metalloproteinase and tissue inhibitor of metalloproteinases Ⅰ expression in human uterine cervical fibroblast. Biol Reprod 2000:62(3)540 -540.

共引文献879

同被引文献66

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部